Download Poster (427.56 KB)

Publication
  • IPIG •
  • 15 May, 2025 •
  • •

Thrombosis and encapsulated bacterial infection rates in patients with paroxysmal nocturnal hemoglobinuria who received pegcetacoplan: Nearly 3 years of post-marketing experience

Gloria F. Gerber, Richard J. Kelly, Hisakazu Nishimori, Regina Horneff, Peter Hillmen, Uchendu O. Uchendu, Yiwei Zhang, Stacie Lallier, Jens Panse

Available materials

Poster
Publication
  • IPIG •
  • 15 May, 2025 •
  • •

Reduced iron overload with pegcetacoplan treatment in eculizumab-experienced patients with Paroxysmal Nocturnal Hemoglobinuria

Jamile Shammo, Michael Yeh, Peter Hillmen, David J. Kuter

Available materials

Poster
Publication
  • IPIG •
  • 15 May, 2025 •
  • •

Real-World Adherence with Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria Compared with Previously Reported Oral Medication Adherence Rates

David Dingli, Brian Mulherin, Peter Hillmen, Barbara Czech, Jens Panse

Available materials

Poster
Publication
  • SEHH-SETH •
  • 10 October, 2025 •
  • •

Interim analysis of the COMPLETE study on the real-world effectiveness of pegcetacoplan in patients with Paroxysmal Nocturnal haemoglobinuria (PNH) in Spain

Carmen Gonzalez Gonzalez, Lavilla Rubira E, Fernández Villar A M, De la Iglesia Íñigo S, Vara Pampliega M, Salido Fiérrez E J, Contento Gonzalo A, Hernández Rodríguez I, Beneitez Pastor D, Gaya Valls A, Elena Surova, Håkan Malmström, Stefan Lethagen

Available materials

Oral Presentation
Publication
  • EHA •
  • 14 June, 2025 •
  • •

A benefit assessment of pegcetacoplan dose increase in the Phase 3 PEGASUS trial of PNH patients with difficult-to-control disease

Morag Griffin, Alexander Röth, Brian Mulherin, Elena Surova, Regina Horneff, Peter Hillmen, Régis Peffault de Latour

Available materials

Poster
Publication
  • EHA •
  • 14 June, 2025 •
  • •

Benefit of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria irrespective of baseline transfusion status

Britta Höchsmann, Ana Boban, Marta Morado, Peter Hillmen, Sheena Patel, Johan Szamosi, Elena Surova, Jens Panse

Available materials

Poster
Publication
  • EHA •
  • 13 June, 2025 •
  • •

Early response in complement inhibitor naïve patients with paroxysmal nocturnal hemoglobinuria treated with pegcetacoplan in the Phase 3 PRINCE trial

Austin G. Kulasekararaj, Elena Solomou, Christopher Patriquin, Peter Hillmen, Sheena Patel, Johan Szamosi, Elena Surova, Alexander Röth

Available materials

Poster
Sign up for alerts